Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
International journal of STD & AIDS·2010
Detection of neuroteratogens with an in vitro cytotoxicity assay using primary monolayers cultured from dissociated foetal rat brains.
Toxicology in vitro : an international journal published in association with BIBRA·2010
A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67.
Annals of oncology : official journal of the European Society for Medical Oncology·2009